LCN2 and metabolic dysfunction-associated steatohepatitis: In particular, emerging evidence has demonstrated that the proteins expressed by azurophil granules [e.g., myeloperoxidase (MPO) and NE] and specific granules [e.g., lipocalin 2 (LCN2)] play a key role in various inflammatory processes during NASH pathogenesis.